Fenway Adolescent Trials Unit
Fenway Adolescent Trials Unit
批准号:
8437095
负责人:
KENNETH H MAYER
金额:
$60.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-06 至 2016-02-29
关键词:
AIDS preventionAIDS/HIV problemAdolescentAdolescent Medicine Trials NetworkAreaBehavioralBostonCaringChildhoodClinicalClinical ResearchColorCommunitiesCommunity HealthCommunity Health CentersDentalDevelopmentDoctor of PhilosophyEducationEnrollmentHIVHIV InfectionsHealthHealth PersonnelIndividualInstitutesInterdisciplinary StudyMedicalMedicineOptometryPharmaceutical ServicesPoliciesPopulationPreventionPrevention ResearchPreventive InterventionPrimary Health CareProviderPublic HealthRecruitment ActivityResearchResearch PersonnelRiskScienceScientistServicesSpecialistTherapeuticTherapeutic Human ExperimentationVaccinesWomanYouthbasebehavioral healthexperiencehealth practiceimprovedinnovationmicrobicideprophylacticresearch studyskillssuccesstransgenderyoung man
中文摘要
描述(由申请人提供):芬威健康,领先的波士顿社区卫生中心进行了二十多年的艾滋病毒/艾滋病研究,建议建立芬威ATU,以促进艾滋病毒感染和高危青年的艾滋病毒预防和治疗研究。芬威ATU是一个多学科的艾滋病毒预防和治疗研究人员和社区卫生服务提供者的合作,在大波士顿的风险和艾滋病毒感染的青少年。芬威健康为1,300多名青少年提供全面的医疗服务,包括:初级保健、行为健康、牙科、验光服务和全方位服务的药房。Fenway Health由以下部门组成:Ansin大楼(医疗和行为健康实践),芬威研究所(研究,教育和政策中心)和Sidney Borum(青少年中心)。由Kenneth H. Mayer,医学博士,行为和生物医学HIV预防和治疗研究的领导者,Michelle Lally,医学博士,高级青少年HIV研究员,Ralph Vetters,医学博士,备受尊敬的青少年和儿科医学提供者和专家,Steven Safren,博士,HIV行为科学家,芬威ATU准备为行为,社区为基础的翻译,预防,治疗,杀菌剂和疫苗试验。该股由经验丰富的临床医生和社区教育工作者组成,他们对社区参与的创新方法成功地使难以接触到的人群参与并保持他们参与一系列研究。我们多样化的临床人群包括有风险的年轻男性,女性和变性人,近60%来自有色人种社区。鉴于我们经验丰富的临床和研究人员,我们难以接触的人群和我们的综合服务合作,芬威ATU准备作出强有力的贡献,以改善研究的访问和促进艾滋病毒预防和治疗的科学为青年。
相关性:艾滋病毒/艾滋病是大波士顿地区青年面临的一个重大公共卫生问题。这一申请证明了波士顿青少年试验单位在艾滋病毒/艾滋病治疗和预防干预领域为青少年医学试验网络(ATN)做出贡献的能力。该股能够接触到通常难以接触和感染艾滋病毒风险较高的人群,并将运用我们的技能,查明和招募这些人群,以促进未感染者和阳性者的艾滋病毒预防科学。
英文摘要
DESCRIPTION (provided by applicant): Fenway Health, the leading Boston community-health center which has conducted HIV/AIDS research for more than two decades, proposes to establish The Fenway ATU in order to contribute to HIV prevention and therapeutic research in HIV infected and at risk youth. The Fenway ATU is a multidisciplinary collaboration of HIV prevention and treatment researchers and community health providers serving at-risk and HIV- infected adolescents in greater Boston. Fenway Health provides comprehensive medical care to over 1,300 adolescents including: primary care, behavioral health, dental, optometry services and a full service pharmacy. Fenway Health is comprised of: the Ansin Building (a medical and behavioral health practice), The Fenway Institute (a center for research, education and policy) and Sidney Borum (a center for youth and adolescents). Led by Kenneth H. Mayer, MD, a leader in behavioral and biomedical HIV prevention and treatment research, Michelle Lally, MD a senior adolescent HIV researcher, Ralph Vetters, MD, a well- respected provider and specialist in Adolescent and Pediatric Medicine and Steven Safren, PhD, a HIV behavioral scientist, the Fenway ATU is prepared to contribute to the development and implementation of behavioral, community-based translational, prophylactic, therapeutic, microbicide and vaccine trials. The Unit comprises of a long-standing staff of experienced clinicians and community educators whose innovative approach to community engagement has garnered success in involving and retaining hard to reach populations into a spectrum of research studies. Our diverse clinical population includes at-risk young men, women and transgender identified individuals with almost 60% being from communities of color. Given our experienced clinical and research staff, our access to hard to reach populations and our integrated service collaborative, the Fenway ATU is prepared to make strong contributions to improving research access and contributing to the science of HIV prevention and treatment for youth.
RELEVANCE: HIV/AIDS is a significant public health problem facing youth in the greater Boston area. This application demonstrates the capacity of Boston Adolescent Trials Unit to contribute to the Adolescent Medicine Trials Network (ATN) in the area of HIV/AIDS treatment and prevention interventions. The Unit has access to populations which are typically hard to reach and at increased risk for HIV acquisition and will implement our skills of identifying and recruiting these populations in order to advance the science of HIV prevention for uninfected and prevention for positives.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fenway Community Health Center, Inc., Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
-
批准号:10599561
-
项目类别:
-
资助金额:$43.35万
-
财政年份:2022
-
负责人:KENNETH H MAYER
-
依托单位:
Fenway Community Health Center, Inc., Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
-
批准号:10709608
-
项目类别:
-
资助金额:$43.61万
-
财政年份:2022
-
负责人:KENNETH H MAYER
-
依托单位:
Evaluation of Life-Steps to Enhance Adherence and Engagement in PrEP Care
-
批准号:10009463
-
项目类别:
-
资助金额:$76.2万
-
财政年份:2019
-
负责人:KENNETH H MAYER
-
依托单位:
Evaluation of Life-Steps to Enhance Adherence and Engagement in PrEP Care
-
批准号:10241375
-
项目类别:
-
资助金额:$76.12万
-
财政年份:2019
-
负责人:KENNETH H MAYER
-
依托单位:
Evaluation of Life-Steps to Enhance Adherence and Engagement in PrEP Care
-
批准号:10683418
-
项目类别:
-
资助金额:$63.79万
-
财政年份:2019
-
负责人:KENNETH H MAYER
-
依托单位:
Evaluation of Life-Steps to Enhance Adherence and Engagement in PrEP Care
-
批准号:10478282
-
项目类别:
-
资助金额:$77.05万
-
财政年份:2019
-
负责人:KENNETH H MAYER
-
依托单位:
Making it last: A randomized, controlled trial of a home care system to promote persistence in PrEP care
-
批准号:10191050
-
项目类别:
-
资助金额:$114.1万
-
财政年份:2017
-
负责人:KENNETH H MAYER
-
依托单位:
Making it last: A randomized, controlled trial of a home care system to promote persistence in PrEP care
-
批准号:9410856
-
项目类别:
-
资助金额:$112.67万
-
财政年份:2017
-
负责人:KENNETH H MAYER
-
依托单位:
Feasibility of Short-Term PrEP Uptake for MSM with Episodic High-Risk for HIV
-
批准号:8845287
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2015
-
负责人:KENNETH H MAYER
-
依托单位:
Optimizing Antiretroviral-Based Prevention by Enhancing PrEP Adherence in MSM
-
批准号:8209569
-
项目类别:
-
资助金额:$20.78万
-
财政年份:2011
-
负责人:KENNETH H MAYER
-
依托单位:
A Pharmacokinetic and Pharmacodynamic Study of an Antibody-based Vaginal Microbi
-
批准号:8329761
-
项目类别:
-
资助金额:$6.74万
-
财政年份:2011
-
负责人:KENNETH H MAYER
-
依托单位:
Optimizing Antiretroviral-Based Prevention by Enhancing PrEP Adherence in MSM
-
批准号:8309932
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2011
-
负责人:KENNETH H MAYER
-
依托单位:
Fenway Adolescent Trials Unit
-
批准号:8616670
-
项目类别:
-
资助金额:$63.13万
-
财政年份:2011
-
负责人:KENNETH H MAYER
-
依托单位:
Structural Factors and HIV and STI Incidence among Young MSM of Color in Boston
-
批准号:8771599
-
项目类别:
-
资助金额:$5.68万
-
财政年份:2011
-
负责人:KENNETH H MAYER
-
依托单位:
Fenway Adolescent Trials Unit
-
批准号:8063296
-
项目类别:
-
资助金额:$61.28万
-
财政年份:2011
-
负责人:KENNETH H MAYER
-
依托单位:
Fenway Adolescent Trials Unit
-
批准号:8250788
-
项目类别:
-
资助金额:$61.56万
-
财政年份:2011
-
负责人:KENNETH H MAYER
-
依托单位:
Fenway Adolescent Trials Unit
-
批准号:8811337
-
项目类别:
-
资助金额:$67.95万
-
财政年份:2011
-
负责人:KENNETH H MAYER
-
依托单位:
Optimizing Antiretroviral-Based Prevention by Enhancing PrEP Adherence in MSM
-
批准号:8471785
-
项目类别:
-
资助金额:$28.07万
-
财政年份:2011
-
负责人:KENNETH H MAYER
-
依托单位:
Clinical Trial Unit for HIV Prevention and Microbicide Research
-
批准号:7923653
-
项目类别:
-
资助金额:$247.2万
-
财政年份:2009
-
负责人:KENNETH H MAYER
-
依托单位:
Clinical Trial Unit for HIV Prevention and Microbicide Research
-
批准号:7683259
-
项目类别:
-
资助金额:$209.78万
-
财政年份:2008
-
负责人:KENNETH H MAYER
-
依托单位: